Abonnez-vous à notre lettre d'information pour rester informé
Cliquez ici
  • BLS

Safety guide: Asbestos

BLS Safety Guide: Asbestos


A guide written by Dr. Antonio Moffa, Dr. Claudia Beccaria and Lucrezia Giorgi of the Unit of Integrated Therapies in Otolaryngology at the University Polyclinic Campus Bio-Medical Foundation in Rome.

 

In the five-year period 2016-2020, an average of about 1,500 workers per year were recognised as having an asbestos-related disease. In the same years, around 50% of workers who contracted asbestos-related diseases suffered a permanent impairment of no more than 25%, while 37% of technopaths died as a result of the occupational disease. Specifically in 2016, the proportion of workers with an impairment of no more than 25 per cent remained almost unchanged, but those with a fatal outcome rose to 43 per cent.

The use of asbestos was banned in Italy in 1992 with Law No. 257, which set the terms and procedures for the cessation of all activities involving the processing and extraction of this mineral. After this date, the only permitted work activities involving exposure to asbestos are its clearance, removal and disposal.

The IARC (International Agency for Research on Cancer) has classified asbestos as a human carcinogen (Group 1).

The danger of asbestos derives from the degree of fibre freedom, i.e. the ability of asbestos-containing materials to release potentially inhalable fibres into the air. Since asbestos is a friable and fibrous material, it is easy for very small particles to be released into the air as a result of any type of stress (processing and handling, vibrations, infiltration of humidity), which, once inhaled, are capable of being deposited in the pulmonary alveoli, bronchi and pleura, causing irreversible tissue damage and the onset of pulmonary diseases. Moreover, as there is no risk threshold below which the concentration of asbestos fibres in the air is not dangerous, it follows that the inhalation of even a single fibre can cause fatal pathologies; clearly, prolonged exposure over time or to high quantities will exponentially increase the likelihood of contracting such pathologies.

The European Commission has recently approved an exposure limit value (or TLV) 10 times lower than the previous one (0.1 fibres/cm3), i.e. 0.01 fibres/cm3, for an 8-hour exposure reference. The harmful effects that occur following the inhalation of asbestos particles are derived from pathogenic mechanisms of an irritative, degenerative and carcinogenic nature and can lead to the onset of various diseases.

The pathologies resulting from breathing in asbestos fibres are all characterised by a long interval between the start of exposure and the appearance of the first symptoms of the disease: this interval, termed 'latency time', can generally last up to decades.

From these pathologies related to exposure to asbestos derives the importance of worker protection, which must be on several fronts: the worker must be equipped with personal respiratory protective equipment with an operational protection factor that ensures that the filtered air inside the PPE is no more than 1/10 of the limit value. The use of PPE must also be interspersed with rest periods appropriate to the physical effort required by the work, and the employer must carry out periodic measurements of the concentration of fibres in the air, reporting the results in the DVR (Risk Assessment Document).

 

 

Recommended products:

 

 

 

Stay informed
Stay safe.

 

Articles Liés

septembre 27, 2022 Préventica Lyon 2022

BLS è a Préventica Lyon 2022 Lione (Francia), 27-29 settembre 2022 Ha avuto inizio l'evento professionale francese di maggiore rilievo per la tutela della salute, della sicurezza e della qualità della vita sul lavoro. Per l'occasione l'Eurexpo di Lione ospita quasi 380 espositori: è una imperdibile opportunità per prevenire i rischi, (re)inventare il lavoro, e […]

Link
avril 11, 2019 BLS is now BSIF member

BLS NorthWest is proud to announce that it is now a British Safety Industry Federation (BSIF) Member and Registered Safety Supplier "Anyone can sell safety, but you shouldn’t buy safety from just anyone" BSIF Members agree to regular annual testing on PPE products, over and above the normal test and CE path that all our products already adhere to. This is done to ensure ongoing compliance and to give our distributors and end users added confidence in quality products and a quality provider.

Link
mars 15, 2022 Filtering facepieces protection

Sapresti dire quali sono le differenze tra una mascherina FFP2 e una FFP3? I facciali filtranti, o Filtering Face Pieces (FFP) proteggono dai cosiddetti "particolati", i quali identificano comunemente diversi tipi di particelle presenti nell'aria: le polveri, le nebbie e i fumi. In questa tipologia di prodotti il livello di protezione viene definito in base […]

Link
Abonnez-vous à la newsletter
Recevez des mises à jour sur nos événements, actualités, catalogue et initiatives à venir.
Souscrire

Nous contacter

Écrivez-nous pour tous vos besoins, nous vous répondrons dans les 48 heures.
Informations requises

BLS S.R.L.
Società a Socio Unico
via dei Giovi, 41 - 20032 Cormano (MI) - Italia
t/f +39 02 39310212 / 66200473
info@blsgroup.it
Privacy Policy - Cookie Policy

Bureau d'inscription
via dei Giovi, 41 – 20032 Cormano (MI) - Italia
Capitale Sociale | Share Capital: Euro 600.000,00 i.v.
C.C.I.A.A. - R.E.A.: MI 1186898
Partita IVA | VAT N°: IT12296780153
C.F. e Iscrizione al Registro delle Imprese di Milano: 07822320151

BLS IBERIA / Av. Pau Casals, 8 08182 Sant Feliu de Codines Barcelona - Spain
BLS NORTHWEST / Reeweg, 132 3343 AP H.I. Ambacht Rotterdam - The Netherlands
BLS DO BRASIL / Rua Alvarenga Peixoto, 307 05095-010 Sao Paulo - SP - Brazil
BLS GERMANY / Dünner Straße 249 D-41066 Mönchengladbach - Germany
BLS FRANCE / 18 Porte du Grand Lyon 01700 Neyron - France

crossmenuchevron-downcross-circle